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Mini review
Practical considerations in refolding proteins from inclusion bodies
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Abstract
Refolding of proteins from inclusion bodies is aﬀected by several factors, including solubilization of inclusion bodies by dena-
turants, removal of the denaturant, and assistance of refolding by small molecule additives. We will review key parameters asso-
ciated with (1) conformation of the protein solubilized from inclusion bodies, (2) change in conformation and ﬂexibility or solubility
of proteins during refolding upon reduction of denaturant concentration, and (3) the eﬀect of small molecule additives on refolding
and aggregation of the proteins.
 2002 Elsevier Science (USA). All rights reserved.
There is a strong demand, due to expansion of ge-
nomic sequence database, on a rapid, large-scale pro-
duction of recombinant proteins. The proteins thus
produced are used to identify their biological functions,
and hence, must be in the native and active conforma-
tion. Since the biological functions of genes and corre-
sponding proteins are unknown, whether the protein is
in the native state or the non-native state cannot be
evaluated by bioassay. There are a number of options
for heterologous recombinant expressions. Among them
Escherichia coli (E. coli) expression is most convenient
and frequently used. Heterologous expression of foreign
genes in E. coli often leads to production of the ex-
pressed proteins in insoluble inclusion bodies (IBs). IBs
must then be solubilized and refolded into an active
conformation. Refolding of IBs is not a straightforward
process, often requiring an extensive trial-and-error
approach. There are two important issues in recovering
active proteins from IBs, i.e., solubilization and refold-
ing. Solubilization must result in monomolecular dis-
persion and minimum non-native intra- or inter-chain
interactions. Choice of solubilizing agents, e.g., urea,
guanidine HCl, or detergents, plays a key role in solu-
bilization eﬃciency, in the structure of the proteins in
denatured state, and in subsequent refolding.
Refolding is initiated by reducing concentration of
denaturant used to solubilize IBs. Protein refolding is
not a single reaction and competes with other reactions,
such as misfolding and aggregation, leading to inactive
proteins. Rate of refolding and other reactions is de-
termined both by the procedure to reduce denaturant
concentration and the solvent condition. This review
focuses on denaturant removal process and solvent ad-
ditives as well as solubilizing conditions.
Idea of using small molecule additives comes from
their in vivo activities. Water-stressed organisms use
them to stabilize the proteins. They are hence named
osmolytes [1,2]. In another instance, mutations that
impair protein folding often result in malfunction of
the proteins, leading to abnormal growth or function of
cells harboring the mutant proteins. It has been shown
that culturing these cells in the presence of certain small
molecule additives can restore the function of the
proteins and render the cells to grow or function nor-
mally. Since the small molecules help the mutant pro-
teins fold correctly, they are called chemical chaperones
[3,4]. Many small molecule additives are both osmo-
lytes and chemical chaperones. Thus, it is evident that
certain small molecules are eﬀective in facilitating
folding and stabilizing proteins or increasing solubil-
ity both in vitro and in vivo. Here, we outline the use
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active proteins and increase the eﬃciency of protein
folding.
Solubilization
Urea, guanidine HCl, and strong ionic detergents
such as N-lauroylsarcosine are solubilizing agents that
are most frequently used. Urea and guanidine HCl lead
to a ﬂexible and disordered structure, while the unfolded
structure in detergents is not well deﬁned. It is well
known that SDS–protein complex assumes a varying
degree of a-helical structure [5,6]. It may be safe to say,
based on the above observation, that proteins solubi-
lized with the detergents have a more ordered structure
than those with urea and guanidine HCl [7].
IBs solubilized in denaturants may be a clear, non-
turbid solution, but may be aggregating as soluble
oligomers. Little is known about the possibility of ag-
gregate formation in denaturant solution. Among these
denaturants, ionic detergents would be the strongest in
dispersing IBs into monomolecular structure due to
strong electrostatic repulsion of detergent/protein com-
plexes.
As described above, detergent/protein complex may
assume non-native secondary structure. Therefore, this
system will work only when native disulﬁdes are
formed in such complex structures. Formation of na-
tive as well as non-native disulﬁdes in Sarkosyl/protein
complexes has been observed, indicating that there are
native and non-native intra-molecular interactions in
detergent/protein complexes (T. Arakawa and T.P.
Horan, unpublished results). This is due to diﬀerences
in structure and dynamics of proteins denatured by
urea or guanidine HCl and by detergents, as described
above.
Urea and guanidine HCl show concentration-depen-
dent binding to the proteins ([8] and S.N. Timasheﬀ,
unpublished), as shown in Fig. 1. In most cases, 6–8M
urea and 6–7M guanidine HCl are required to achieve
extensive binding suﬃcient to unfold and solubilize the
proteins. However, even at the highest concentration
intra- and inter-molecular interactions can occur [9],
often resulting in non-native structure, as schematically
depicted in Fig. 2. Such a non-native structure can lead
to aggregation or misfolding upon removal of denatur-
ant. For disulﬁde-containing proteins, native disulﬁdes
may form, even in the unfolded state with concentrated
denaturant when native interactions are more favorable.
In the intermediate concentrations, binding of denatur-
ant molecules (for urea and guanidine HCl) is less (Fig.
1), and hence, the protein molecules begin to refold.
Therefore, it is possible to modulate binding of urea and
guanidine HCl for more eﬃcient refolding. This is not
the case for detergents. Binding of a detergent is deter-
mined by critical micelle concentration. Micelle-like
binding occurs above CMC where unfolded proteins are
highly soluble, while little binding occurs below CMC
where protein solubility is greatly reduced [10]. This
dictates that refolding must occur in the presence of
detergent, since otherwise, upon removal of the deter-
gent, the protein structure and solubility go back to
those in IBs.
Fig. 1. Binding of urea (r) and guanidine HCl () to oxidized lyso-
zyme. Lysozyme used in this experiment has an intact disulﬁde struc-
ture. When disulﬁdes are reduced (as in inclusion bodies), a larger
binding of urea or guanidine HCl occurs. Binding measurements were
done by equilibrium dialysis. Data are taken from T. Arakawa and
S.N. Timasheﬀ (unpublished).
Fig. 2. Non-native intra- and inter-molecular interactions. This model
protein has an inter-helical interaction (Aand B) and hydrophobic
regions (C and D) far apart from each other in the native state (upper
panel). The helical interaction is abolished in the unfolded state, while
non-native hydrophobic interaction between region C and D occurs
intra-molecularly (middle panel) or inter-molecularly (lower panel).
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Refolding is a change in protein conformation from
unfolded to folded state. IBs can be solubilized only by
strong denaturants, whereby the proteins are unfolded,
the extent of which depends on the proteins and the type
of the denaturants used. The solubilized proteins from
IBs are also highly ﬂexible, solvated, and soluble. Unlike
in refolding studies using puriﬁed proteins, solubilized
IBs contain impurities, which may associate with the
expressed protein and interfere with its refolding. Prior
puriﬁcation may be required to minimize such interfer-
ence by impurities.
As schematically shown in Fig. 3, refolding is a pro-
cess that leads to a change in protein conformation from
unfolded to folded (native) state. At high denaturant
concentrations, proteins are unfolded (disordered), well
solvated, and ﬂexible. In aqueous buﬀer, proteins are
folded, rigid, and compact. Ideally, transfer of protein
molecules from high denaturant concentration to
aqueous buﬀer should lead to refolding, i.e., transfer of
protein molecules from denaturant solution to aqueous
solvent will force them to collapse into a compact
structure. However, such a drastic process usually does
not work, since it will lead to misfolding and aggrega-
tion. Once misfolded or aggregated, in the absence of
denaturants protein molecules have no ﬂexibility to
disaggregate and refold into the native structure. As
shown in Fig. 3, a key to refolding is in the intermediate
concentration of the denaturant, where denaturant
concentration is low enough to force protein molecules
to collapse, yet can allow them to stay in solution and be
ﬂexible to reorganize their structures. In other words,
intermediate concentration of denaturants can induce
folding and still maintain solubility and ﬂexibility during
refolding. Which intermediate concentration works
depends on the proteins and how the denaturant con-
centration is reduced.
Equilibrium unfolding studies have demonstrated the
existence of an intermediate structure (I) in the inter-
mediate concentrations of denaturant. Such intermedi-
ate structures also form during refolding, as depicted in
Fig. 4. The intermediate structure is unstable and less
soluble and as a consequence readily misfolds and ag-
gregates. It is therefore important to facilitate folding of
the intermediate into the more stable native structure
(N), yet maintain the solubility and ﬂexibility of the
intermediate. In connection with protein refolding,
however, optimal procedure to reduce denaturant con-
centration and assistance of refolding by solvent addi-
tives play a key role whether protein folding goes
through intermediate structure or occurs directly from
unfolded to folded state.
Disulﬁde-containing proteins can refold even in
concentrated denaturant, as depicted in Fig. 5. Namely,
protein molecules in such solvent can still ﬂuctuate be-
tween unfolded and native-like structure and can form
the native disulﬁde bonds [U(SS)]. However, the rate
and probability of native disulﬁde formation will be
slow in concentrated denaturant. Bringing the protein to
lower denaturant concentration will accelerate disulﬁde
formation, whether conformational transition is of two-
state (Fig. 5, panel A) or of three-state (panel B). There
is a balance here again that low denaturant concentra-
tion will increase the rate of refolding, but may force
proteins to collapse into misfolded with resultant for-
mation of non-native disulﬁdes. Once such a structure is
formed, it may not refold to the native structure, since
insuﬃcient denaturant concentration may make pro-
teins structure too rigid to reorganize.
Even though native disulﬁde bonds are formed in the
presence of denaturant, it does not guarantee that the
Fig. 3. Conformation, ﬂexibility, and solubility of protein as a function
of denaturant concentration. Degree of folding is plotted against de-
naturant concentration. Physical properties of protein solution are
given at high and low sides of concentration of denaturant.
Fig. 4. Schematic diagram of refolding course. U, I, andN correspond
to the unfolded, intermediate, and native state of protein, respectively.
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turant. Proteins are still largely unfolded even with na-
tive disulﬁdes formed and sudden removal of the
denaturant may cause a collapse into a wrong confor-
mation. The way by which the denaturant is removed
can aﬀect refolding eﬃciency.
In this discussion, it should be noted that detergent
will behave diﬀerently. Detergent binding is character-
ized as micelle-like binding above CMC and stoichi-
ometric (mono-molecular) binding below CMC (Fig. 6).
Proteins are quite insoluble in stoichiometric binding,
while highly soluble in micelle-like binding [10]. There is
no intermediate binding or structure, so if disulﬁdes are
not formed while proteins are soluble in protein–deter-
gent complex, detergent concentration cannot be re-
duced below CMC to induce folding.
Refolding is determined by a balance between struc-
ture collapse and ﬂexibility or solubility of the inter-
mediates (or the unfolded structure). This balance aﬀects
the refolding course. Folding into native structure
competes with misfolding or aggregation. Therefore,
optimal refolding can be achieved by forcing denatured
protein to collapse on one hand, yet by maintaining
solubility and ﬂexibility of the molecule on the other
hand. Such balance can be manipulated by two diﬀerent
means. One is the way by which denaturant concentra-
tion is reduced. Any procedure, for example, whether it
is dialysis or dilution, must go through intermediate
denaturant concentration. Both how fast the denaturant
concentration is reduced and how long the protein
molecules are exposed to intermediate denaturant con-
centration determine the rate of folding and the degree
of ﬂexibility or solubility of folding intermediates. In
addition, the rate of folding vs. misfolding or aggrega-
tion can be manipulated by small molecule additives.
There are certain additives that enhance structure for-
mation or collapse, while others increase ﬂexibility or
solubility of the proteins. Here, we describe these two
parameters separately, but refolding should be opti-
mized by combining these two parameters. First, we
discuss about various protocols to reduce denaturant
concentration.
Refolding
One-step dialysis
Denatured, unfolded protein samples in concentrated
denaturant solution are dialyzed against a refolding
buﬀer, and hence, exposed to descending concentration
of the denaturant. Denaturant concentration decreases
with time to the concentration of refolding solvent (Fig.
7A). As the concentration of denaturant is decreased,
the rate of folding into the intermediate and native
structures increases. However, the rate of misfolding or
aggregation will also increase. In particular, aggregation
can be greatly enhanced, if the rate of folding is slow,
since the moderate to low denaturant concentration may
not be enough to keep the unfolded or intermediate
structures soluble. In dialysis refolding, the intermediate
structure can be exposed to intermediate denaturant
concentration for a prolonged period. This protocol
should have a better chance of success for those proteins
which are soluble even in the unfolded or intermediate
state. Note that while denaturant concentration de-
creases, protein concentration remains relatively con-
stant, except for volume expansion due to high
osmolality of guanidine HCl or urea. This means that
the initial protein concentration in the denaturant is
critical.
Step-wise dialysis
This protocol uses descending concentration of de-
naturant for dialysis and has been successfully used for
Fig. 6. Detergent binding as a function of concentration Astrong
detergent such as Sarkosyl exhibits a micelle-like binding above CMC
and a stoichiometric binding below CMC.
Fig. 5. Protein folding and disulﬁde formation. Panels Aand B show
the formation of disulﬁde bonds and conformational change during
two- and three-state transition, respectively.
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ﬁrst brought to equilibrium with high denaturant con-
centration (Fig. 7B-1), then with middle concentration
(Fig. 7B-2), and with low concentration (Fig. 7B-3).
Diﬀerence from the one-step dialysis is the establishment
of equilibrium at each denaturant concentration. This
does not work if the rate of misfolding or aggregation
kmis/agg (Fig. 8) is faster than the rate of refolding, kref.
An advantage in this protocol is that the return to
correct refolding pathway kex may occur, in particular
for disulﬁde-containing proteins in redox disulﬁde ex-
change reaction, at intermediate denaturant concentra-
tion. At each denaturant concentration, folding
intermediate may form the misfold or aggregate. How-
ever, intermediate concentration of denaturant may al-
low the protein molecule to ﬂuctuate and convert to the
native structure with correct disulﬁdes formed. Another
advantage may be aﬀorded on multi-domain proteins, if
the folding or stability of each domain is diﬀerent.
Equilibration at higher denaturant concentration may
result in folding of the most stable domain. It is possible
that folding of this particular domain is more favorable
at higher denaturant concentration than at lower con-
centration and simultaneous refolding with less stable
domains, in one-step dialysis, may cause misfolding.
Descending denaturant concentration dialysis
As shown in Fig. 7C, this is one-step dialysis against
descending concentration of denaturant [13]. The un-
folded protein sample at high denaturant concentration
is placed in dialysis bag and immersed in the denaturant
solution. This dialyzing solvent is pumped out and the
ﬁnal buﬀer (refolding solvent) is pumped in. The rates of
pumping-out and -in determine the gradient of dena-
turant concentration reduction. If the rate is fast, it is
similar to one-step dialysis, while, in slow rate, it re-
sembles multi-step dialysis.
Buﬀer-exchange by gel ﬁltration
Gel ﬁltration column is equilibrated with the ﬁnal
refolding buﬀer. Unfolded protein sample in denaturant
is applied to the column and run through it with the
refolding buﬀer. Use of desalting column will separate
proteins from denaturant, while use of protein-sizing
column will fractionate protein species. In any case,
gradual change in denaturant concentration occurs as in
one-step dialysis. The same problems that occur in di-
alysis refolding may be encountered here. If the un-
folded or intermediate folded structure converts more
slowly to the native state than to the misfolds or ag-
gregates, there may not be enough time for the misfolds
to exchange into the native structure in the descending
concentration of denaturant. Alternately, a prolonged
exposure to intermediate denaturant concentration may
cause protein aggregation or misfolding. Adiﬀerence
from dialysis is the environment of column matrix sur-
rounding proteins during folding. Column matrix may
Fig. 8. Refolding and aggregation. The parameters, kref, kmis/agg, and
kex, are the rate of refolding from I to N, the rate of misfolding or
aggregation, and the rate of the reverse reaction from misfold or ag-
gregate to I. Folding enhancer enhances the reaction of both U to I
and I to N, while aggregation suppressor reduces the reaction rate
from I to misfold or aggregate.
Fig. 7. Dialysis refolding. Panel A: change in denaturant concentration
during dialysis. Panel B: step-wise dialysis from high denaturant con-
centration (1), via middle concentration (2), and to low concentration
(3). Panel C: in this dialysis, unfolded protein in dialysis bag is equil-
ibrated with solubilizing solvent (high denaturant). Final solvent is
pumped in and the dialyzing solution is pumped out. This will generate
a descending concentration of denaturant in refolding solvent during
dialysis.
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drophobic interaction, during folding under the inter-
mediate denaturant concentration that may prevent
misfolding or aggregation. Column matrix may also
help proteins disperse, reducing aggregation. This pro-
tocol was successfully used for refolding IL-6 from
guanidine HCl [14]. In this case, IL-6 was oxidized to
form correct disulﬁdes in guanidine HCl and then re-
folded by gel ﬁltration on G-25 column equilibrated
with refolding buﬀer. This also demonstrates that cor-
rect disulﬁde formation is prerequisite, but insuﬃcient
for IL-6 refolding. An optimal procedure to remove
guanidine HCl is essential to lead to a native structure,
even after the correct disulﬁdes are formed.
Dilution
Protein samples at high denaturant concentration are
delivered into a large volume of refolding buﬀer. Dilu-
tion brings the unfolded sample into a rapid collapse,
whereby bypassing the intermediate denaturant con-
centration. There are a few parameters to be considered.
First, as shown in Fig. 9 (normal dilution), both the
denaturant and protein concentrations increase, as the
unfolded protein in concentrated denaturant is deliv-
ered, e.g., from 0 (refolding solvent) to 1M (ﬁnal con-
centration) if a protein in 6M guanidine HCl is diluted
6-fold (at the end of dilution) into a buﬀer. This means
that earlier part of dilution (where denaturant concen-
tration is close to zero) is very diﬀerent from later part
(where denaturant concentration is close to 1M). Dilu-
tion into a buﬀer means a collapse into a rigid structure
which cannot ﬂuctuate or convert to the native struc-
ture, without the presence of low concentration of de-
naturant. It is therefore recommended to include some
level of denaturant, the concentration of which depends
on the stability of the protein to be refolded. Second, for
oligomeric proteins, the earlier part of dilution means
low protein concentration during refolding. Therefore,
slow dilution may result in insuﬃcient concentration of
refolded, monomeric state for a prolonged period, and
hence, rapid dilution may be recommended. Third, if
lower protein concentration is required to avoid aggre-
gation, pulsed-dilution may work better, as described
below.
Reverse dilution
Reverse dilution is done by adding refolding buﬀer
into an unfolded protein containing concentrated de-
naturant such that both the denaturant and protein
concentrations decrease simultaneously (Fig. 9. reverse
dilution). This results in exposure of unfolded or inter-
mediate protein molecules to descending denaturant
concentration for a prolonged period. Unlike dilution,
protein concentration is high at intermediate denaturant
concentration. Such conditions result in aggregation and
precipitation. However, if the intermediate structure is
soluble in the intermediate denaturant concentration
and refolding requires slow structure rearrangement,
this protocol may be desirable.
Mixing
Refolding solvent and unfolded protein solution are
mixed at a constant ratio. With this procedure, both
protein and denaturant concentrations during refolding
are maintained constant (Fig. 10, upper panel), unlike
dilution or reverse dilution. The course of protein
folding is similar to that in dilution procedure, i.e.,
mixing leads to a rapid collapse of the protein into an
intermediate structure.
Fig. 9. Dilution refolding. Left panel, normal dilution. Right panel,
reverse dilution.
Fig. 10. Refolding by mixing. Unfolded protein and refolding solvent
are delivered, e.g., via pump, into a mixer at a constant ratio. Mixing at
constant ratio maintains both denaturant and protein concentrations
constant during refolding.
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Dilution is made in aliquot, rather than in continuous
mode. In pulsed dilution, after an aliquot of denatured
protein solution is diluted into a refolding solvent, re-
folding is allowed to occur for some period before ad-
dition of the next aliquot. This will avoid accumulation
of high concentration of folding intermediates that oc-
cur in one-step dilution. This has an advantage when the
folded structure does not aggregate with the unfolded or
folding intermediates.
Solid phase refolding
Denatured protein is ﬁrst non-covalently bound to
solid matrix such as Ni-resin or ion-exchange resin in the
presence of denaturant (Fig. 11). Denaturant concen-
tration is then decreased to initiate refolding. Since
protein molecules are bound to resin, this procedure
minimizes aggregation of unfolded protein or folding
intermediates. Binding of proteins to solid phase can be
multivalent, which renders protein folding impossible
(Fig. 11, lower panel). Even when it is monovalent,
folding may be interfered with due to steric hindrance or
binding sites on protein molecule being important for
folding. To overcome this problem, refolding may be
carried out under weakly dissociating conditions, where
protein to be refolded ﬂuctuates between bound and
unbound states in the resin.
Co-solute assistance
Small molecules (co-solutes) are usually added to
refolding solvent to facilitate refolding. In general, in
particular for refolding by dilution, low concentration of
urea or guanidine HCl is included in refolding solvent.
This concentration is low enough for eﬃcient refolding,
yet high enough to maintain solubility and ﬂexibility of
folding intermediates. However, inclusion of urea or
guanidine HCl alone is insuﬃcient and addition of co-
solutes is often essential. Without it, refolding generates
a varying degree of aggregates or misfolds. Co-solutes
may be classiﬁed into two groups, folding enhancer and
aggregation suppressor as summarized in Table 1. Such
distinctive eﬀects are schematically depicted in Fig. 8.
These two groups may be exclusive, since folding en-
hancer in principle enhances protein–protein interac-
tions, while aggregation suppressor reduces side chain
interactions. Aggregation suppressor reduces associa-
tion of folding intermediates without interfering with
refolding process. It encompasses polyethylene glycol
[15], cyclodextrin [16], arginine HCl [17,18], and proline
[19–21]. Polyethylene glycol and cyclodextrin bind to the
hydrophobic region of the folding intermediate. Among
these co-solutes, arginine HCl is most frequently used. It
is not clear, however, how arginine HCl reduces aggre-
gation of folding intermediates. It is clear from its eﬀect
on protein stability that arginine HCl is not a protein
stabilizer nor folding enhancer. There are many polar
small molecule additives that enhance protein stability
[22–27] and also in vivo protein folding [28–30]. These
encompass sugars, polyols, certain salts such as ammo-
nium sulfate and magnesium chloride, and certain
amino acids such as glycine and alanine. Although these
will enhance protein to collapse into a compact struc-
ture, they may also enhance misfolding and aggregation.
Such collapsed structure may be too compact and rigid,
Fig. 11. Refolding on column. Two types of protein binding in dena-
turant solution are shown. In type A, unfolded protein has two con-
tacts with the solid matrix, one through terminal His-tag, and another
through an amino acid residue in the polypeptide. Such multiple
contacts can lead to misfolding. In type B, unfolded protein binds only
through terminal His-tag and is refolded into the native structure.
Table 1
Classiﬁcation of small molecule additives
Classiﬁcation Model co-solute Eﬀect on protein stability Eﬀect on protein–protein interaction
Folding enhancer Sucrose Stabilizer Enhance
Ammonium sulfate
Aggregation suppressor Arginine Neutral Reduce
Mild detergent
Denaturant Urea Destabilizer Reduce
Guanidine HCl
Strong detergent
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into the native state. Reduced ﬂexibility by protein sta-
bilizers, i.e., sucrose, has been shown by H-D exchange
experiments [31]. They may be useful when the unfolded
or folding intermediates are too soluble and cannot be
readily converted to a more compact structure. It has
been shown that a-synuclein, highly soluble even in the
unfolded state, can attain a certain folded structure in
the presence of trimethylamine-N-oxide, a strong pro-
tein stabilizer [32].
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